Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

The National Institutes of Health is seeking applications for the Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science grant opportunity. Funded projects will support the development and demonstration of unique hub capabilities, research platforms, and resources to address critical gaps and roadblocks in clinical and translational science at awarded Clinical and Translational Science Award Program Hubs. Eligibility is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards UM1 funding opportunity. Applications will undergo standard peer-review processes, and only those determined to be highly meritorious will be considered for funding. The estimated synopsis close date is January 25, 2027, and inquiries can be directed to the Division of Clinical Innovation, NCATS at RC2NOFO@nih.gov.